Bayesian designs for phase I-II clinical trials / Ying Yuan, Hoang Q. Nguyen, Peter F. Thall.
Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same time, if promising preclinical results do not translate into a real treatment advance, it is important to determ...
Saved in:
| Online Access: |
Full Text (via Taylor & Francis) |
|---|---|
| Main Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
Boca Raton :
Chapman & Hall/CRC,
2016.
|
| Edition: | 1st. |
| Series: | Chapman & Hall/CRC biostatistics series.
|
| Subjects: |
Internet
Full Text (via Taylor & Francis)Online
| Call Number: |
R853.C55
|
|---|---|
| R853.C55 | Available |